Champions Oncology, Inc. (CSBR) financial statements and ratios from SEC XBRL: revenue $59.42M (TTM), net margin -2.0%, revenue growth 4.4% YoY, P/E 17.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $59.42M |
| Net Margin | -2.0% |
| Revenue Growth (YoY) | 4.4% |
| EPS Growth (YoY) | -123.5% |
| FCF Growth (YoY) | -172.0% |
| P/E Ratio | 17.6 |
| EV / EBITDA | 12.3 |
| Price / Book | 17.28 |
| Price / Sales | 1.12 |
| FCF Yield | -4.7% |
| Altman Z-Score | -0.33 (distress) |
| Sector P/E (Healthcare) | 21.7 |
CSBR overview · CSBR earnings · CSBR KPIs · CSBR investor relations · CSBR ownership · CSBR peers · CSBR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.